Insights

Expertise in Ophthalmic Trials 20/20 Onsite specializes in mobile eye assessments tailored for clinical trials, positioning it as a key partner for biotech and pharmaceutical companies seeking reliable ocular endpoint data and participant retention solutions.

Strong Industry Recognition Winning awards like the Safety Excellence Award and forming strategic partnerships with organizations such as The Vision Council Foundation and Boston Public Schools demonstrate credibility and a solid track record, making it appealing to organizations prioritizing quality and safety.

Community and Outreach Initiatives Active involvement in public health programs and collaborations with educational institutions highlight potential opportunities to expand into health outreach and community-based eye health initiatives for public sector contracts and corporate social responsibility programs.

Growing Revenue and Funding With a revenue range between 25 and 50 million dollars and recent strategic partnerships, there is a clear upward trajectory that might interest investors and clients seeking innovative, scalable ophthalmic solutions with proven impact.

Technology-Enabled Service Delivery The company's use of multiple tech solutions for service delivery indicates a modern, efficient approach that can be leveraged to appeal to healthcare organizations seeking integrated, technology-driven ophthalmic trial solutions.

20/20 Onsite Tech Stack

20/20 Onsite uses 8 technology products and services including Section.io, Open Graph, Apple iCloud Mail, and more. Explore 20/20 Onsite's tech stack below.

  • Section.io
    Content Delivery Network
  • Open Graph
    Content Management System
  • Apple iCloud Mail
    Email
  • Linkedin Sign-in
    Identity Verification
  • Tiny Slider
    Javascript Libraries
  • Slick
    Javascript Libraries
  • HubSpot Chat
    Live Chat
  • Facebook
    Widgets

Media & News

20/20 Onsite's Email Address Formats

20/20 Onsite uses at least 1 format(s):
20/20 Onsite Email FormatsExamplePercentage
FLast@2020onsite.comJDoe@2020onsite.com
48%
First@2020onsite.comJohn@2020onsite.com
4%
FLast@2020onsite.comJDoe@2020onsite.com
48%

Frequently Asked Questions

Where is 20/20 Onsite's headquarters located?

Minus sign iconPlus sign icon
20/20 Onsite's main headquarters is located at 222 Berkeley Street, 12th Floor. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is 20/20 Onsite's phone number?

Minus sign iconPlus sign icon
You can contact 20/20 Onsite's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is 20/20 Onsite's official website and social media links?

Minus sign iconPlus sign icon
20/20 Onsite's official website is 2020onsite.com and has social profiles on LinkedInCrunchbase.

What is 20/20 Onsite's SIC code NAICS code?

Minus sign iconPlus sign icon
20/20 Onsite's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 20/20 Onsite have currently?

Minus sign iconPlus sign icon
As of January 2026, 20/20 Onsite has approximately 69 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: S. B.Chief Medical Officer: D. G.Chief Medical Officer: D. G.. Explore 20/20 Onsite's employee directory with LeadIQ.

What industry does 20/20 Onsite belong to?

Minus sign iconPlus sign icon
20/20 Onsite operates in the Biotechnology Research industry.

What technology does 20/20 Onsite use?

Minus sign iconPlus sign icon
20/20 Onsite's tech stack includes Section.ioOpen GraphApple iCloud MailLinkedin Sign-inTiny SliderSlickHubSpot ChatFacebook.

What is 20/20 Onsite's email format?

Minus sign iconPlus sign icon
20/20 Onsite's email format typically follows the pattern of FLast@2020onsite.com. Find more 20/20 Onsite email formats with LeadIQ.

How much funding has 20/20 Onsite raised to date?

Minus sign iconPlus sign icon
As of January 2026, 20/20 Onsite has raised $4M in funding. The last funding round occurred on Aug 12, 2020 for $4M.

When was 20/20 Onsite founded?

Minus sign iconPlus sign icon
20/20 Onsite was founded in 2013.

20/20 Onsite

Biotechnology ResearchMassachusetts, United States51-200 Employees

2020 Onsite (also known as 20/20 Onsite) is the only provider solely dedicated to point-of-need eye assessments for clinical trials, proven to meet screening timelines, improve retention rates, and fast-track trials.

With over 85,000 eye exams performed, support for 45 clinical trials,  and an average of 11+ years of ophthalmic expertise per clinical employee, 20/20 Onsite delivers unmatched mobile ophthalmic experience for clinical trials. Our innovative approach can reduce participant dropout rates to just 9%, compared to the industry standard of 30%. 

With research at risk, ensure quality ocular endpoint protection with 2020 Onsite (20/20 Onsite).

Section iconCompany Overview

Headquarters
222 Berkeley Street, 12th Floor
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $4M

    20/20 Onsite has raised a total of $4M of funding over 5 rounds. Their latest funding round was raised on Aug 12, 2020 in the amount of $4M.

  • $25M$50M

    20/20 Onsite's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $4M

    20/20 Onsite has raised a total of $4M of funding over 5 rounds. Their latest funding round was raised on Aug 12, 2020 in the amount of $4M.

  • $25M$50M

    20/20 Onsite's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.